Prognostic Significance of the Number of Removed and Metastatic Lymph Nodes and Lymph Node Ratio in Breast Carcinoma Patients with 1–3 Axillary Lymph Node(s) Metastasis

<table>Locoregional recurrence-free survival rates according to lymph node ratio (LNR) in the whole series. LNR ≤ 0.30 (797 patients) versus LNR &gt; 0.30 (127 patients) (log-rank <svg height="13.9125" id="M7" style="vertical-align:-0.11285pt" version="1.1" viewbox="0 0 14.8125 13.9125" width="14.8125" xmlns="http://www.w3.org/2000/svg">
<g transform="matrix(1.25,0,0,-1.25,0,13.9125)">
<g transform="translate(72,-60.87)">
<text transform="matrix(1,0,0,-1,-71.95,61.03)">
<tspan style="font-size: 12.50px; " x="0" y="0">𝑥</tspan>
</text>
<text transform="matrix(1,0,0,-1,-65.07,66.03)">
<tspan style="font-size: 8.75px; " x="0" y="0">2</tspan>
</text>
</g>
</g>
</svg> = 17.611, <i>P </i>&lt; 0.001).</table>

International Scholarly Research Notices

fig3

Figure 3

Figure 3: Prognostic Significance of the Number of Removed and Metastatic Lymph Nodes and Lymph Node Ratio in Breast Carcinoma Patients with 1–3 Axillary Lymph Node(s) Metastasis 

Figure 3 | Prognostic Significance of the Number of Removed and Metastatic Lymph Nodes and Lymph Node Ratio in Breast Carcinoma Patients with 1–3 Axillary Lymph Node(s) Metastasis 